A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

PHASE3CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

DiphtheriaPertussisTetanusHepatitis BHaemophilus Infections

Interventions

BIOLOGICAL

Quinvaxem in Uniject

BIOLOGICAL

Quinvaxem in single dose vials

Trial Locations (1)

Research Institute for Tropical Medicine, City of Muntinlupa

All Listed Sponsors

lead

Crucell Holland BV

INDUSTRY

NCT01917357 - A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject | Biotech Hunter | Biotech Hunter